The human immunodeficiency virus (HIV) is the causative agent for the acquired immune deficiency syndrome (AIDS). It is predicted that globally approximately 33,000,000 individuals are currently infected with HIV. Although a number of significant advances have been made to our understanding of the molecular and cellular biology of HIV, our understanding of the pathogenesis of AIDS remains less well understood. Despite numerous efforts, vaccination attempts have largely failed. Likewise, although therapy is highly effective, the mechanisms by which HIV becomes resistant to drugs are less clearly defined. For fourteen years the Palm Springs Symposium on HIV/AIDS has been one of the leading national meetings bringing together experts and young investigators to discuss research on HIV and on AIDS. The symposium offers evolving topics on an annual basis that cover pathogenesis, vaccines, and drug development. The topics for 2009-2011 are proposed as """"""""HIV and the Immune System: Back to Basics"""""""", """"""""Novel Drug Targets and Mechanisms of Resistance"""""""", and """"""""Molecular Mechanisms Leading to AIDS"""""""", respectively. Twenty invited speakers have been identified and have accepted their invitations for the 2009 meeting. A similar number of speakers will be invited to subsequent meetings. Continuing this intimate meeting is important for the community of HIV/AIDS investigators to share data, to form collaborations, and to make progress on the elimination of AIDS as an illness.

Public Health Relevance

The human immunodeficiency virus (HIV) currently infects more than 1million Americans. The Palm Springs HIV/AIDS Symposium brings together experts from all across the United States to discuss their research to better understand how HIV causes the acquired immune deficiency syndrome (AIDS) and ultimately, death. This meeting greatly improves our likelihood of eliminating AIDS from North America.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Conference (R13)
Project #
2R13AI068368-04
Application #
7685546
Study Section
Special Emphasis Panel (ZAI1-IPG-M (J1))
Program Officer
Gutierrez, Martin
Project Start
2006-01-01
Project End
2012-01-31
Budget Start
2009-02-15
Budget End
2010-01-31
Support Year
4
Fiscal Year
2009
Total Cost
$20,000
Indirect Cost
Name
University of California Irvine
Department
Internal Medicine/Medicine
Type
Organized Research Units
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697